Impulsivity is related to striatal dopamine transporter availability in healthy males

Psychiatry Research - Neuroimaging

Volumn 211, Issue 3, 2013, Pages 251-256

  Costa, Anna ^a   la Fougère, Christian ^a   Pogarell, Oliver ^a   Möller, Hans Jürgen ^a   Riedel, Michael ^a,b   Ettinger, Ulrich ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Vinzenz von Paul Hospital   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

ADHD; ASRS; BIS; Dopamine transporter; Neuroticism; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE I 123;

ADHD SELF REPORT SCALE; ADULT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; BARRATT IMPULSIVENESS SCALE; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; EMOTIONALITY; HUMAN; HUMAN EXPERIMENT; HYPERACTIVITY; IMPULSIVENESS; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IMPULSIVE BEHAVIOR; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REGRESSION ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; YOUNG ADULT;

EID: 84875370933     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2012.07.011     Document Type: Article

References (65)

1. Aichert D.S., Wöstmann N.M., Costa A., Macare C., Wenig J.R., Möller H.J., Rubia K., Ettinger U. Associations between Trait Impulsivity and Prepotent Response Inhibition. Journal of Experimental and Clinical Neuropsychology 2012, 34(10):1016-1032.
2. Amsterdam J.D., Newberg A.B. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology 2007, 55:167-170.
3. Bachorowski J.A., Newman J.P. Impulsive motor behavior: effects of personality and goal salience. Journal of Personality and Social Psychology 1990, 58:512-518.
4. Beck A., Schlagenhauf F., Wustenberg T., Hein J., Kienast T., Kahnt T., Schmack K., Hagele C., Knutson B., Heinz A., Wrase J. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biological Psychiatry 2009, 66:734-742.
5. Borkenau P., Ostendorf F. Ein Fragebogen zur Erfassung fünf robuster Persönlichkeitsfaktoren. Diagnostica 1991, 37:29-41.
6. Buckholtz J.W., Treadway M.T., Cowan R.L., Woodward N.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Shelby E.S., Smith C.E., Kessler R.M., Zald D.H. Dopaminergic network differences in human impulsivity. Science 2010, 329:532.
7. Burke S.M., van de Giessen E., de Win M., Schilt T., van Herk M., van den Brink W., Booij J. Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects. Psychological Medicine 2011, 41:419-429.
8. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., Sahakian B.J. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neuroscience and Biobehavioral Reviews 2005, 29:399-419.
9. Chambers C.D., Garavan H., Bellgrove M.A. Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neuroscience and Biobehavioral Reviews 2009, 33:631-646.
10. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science 1978, 25:638-643.
11. Ciliax B.J., Drash G.W., Staley J.K., Haber S., Mobley C.J., Miller G.W., Mufson E.J., Mash D.C., Levey A.I. Immunocytochemical localization of the dopamine transporter in human brain. Journal of Comparative Neurology 1999, 409:38-56.
12. Claridge G., Davis C. What's the use of neuroticism?. Personality and Individual Differences 2001, 31:383-400.
13. Cools R., Sheridan M., Jacobs E., D'Esposito M. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. Journal of Neuroscience 2007, 27:5506-5514.
14. Costa, A., Riedel, M., Pogarell, O., Menzel-Zelnitschek, F., Schwarz, M., Rubia, K., Reiser, M., Möller, H.J., Meindl, T., Ettinger, U., 2012. Methylphenidate effects on neural activity during response inhibition in healthy humans. Cerebral Cortex. electronic publication 10 May, http://dx.doi.org/10.1093/cercor/bhs107.
15. Congdon E., Canli T. A neurogenetic approach to impulsivity. Journal of Personality 2008, 76:1447-1484.
16. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Lääne K., Peña Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
17. de Wit H., Enggasser J.L., Richards J.B. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002, 27:813-825.
18. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., Fischman A.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999, 354:2132-2133.
19. Dresel S., Krause J., Krause K.H., LaFougere C., Brinkbaumer K., Kung H.F., Hahn K., Tatsch K. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. European Journal of Nuclear Medicine 2000, 27:1518-1524.
20. Ersche K.D., Turton A.J., Pradhan S., Bullmore E.T., Robbins T.W. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biological Psychiatry 2010, 68:770-773.
21. Ettinger U., Kumari V., Chitnis X.A., Corr P.J., Crawford T.J., Fannon D.G., O'Ceallaigh S., Sumich A.L., Doku V.C., Sharma T. Volumetric neural correlates of antisaccade eye movements in first-episode psychosis. American Journal of Psychiatry 2004, 161:1918-1921.
22. Ettinger U., Kumari V., Crawford T.J., Flak V., Sharma T., Davis R.E., Corr P.J. Saccadic eye movements, schizotypy, and the role of neuroticism. Biological Psychology 2005, 68:61-78.
23. Eysenck H.J., Barrett P. The nature of schizotypy. Psychological Reports 1993, 73:59-63.
24. Fusar-Poli P., Rubia K., Rossi G., Sartori G., Balottin U. Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. American Journal of Psychiatry 2012, 169:264-272.
25. Greenhill L.L., Halperin J.M., Abikoff H. Stimulant medications. Journal of the American Academy of Child and Adolescent Psychiatry 1999, 38:503-512.
26. Hershey T., Black K.J., Hartlein J., Braver T.S., Barch D.M., Carl J.L., Perlmutter J.S. Dopaminergic modulation of response inhibition: an fMRI study. Cognitive Brain Research 2004, 20:438-448.
27. Kessler R.C., Adler L., Ames M., Demler O., Faraone S., Hiripi E., Howes M.J., Jin R., Secnik K., Spencer T., Ustun T.B., Walters E.E. The world health organisation adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychological Medicine 2005, 35:245-256.
28. 123I]IPT SPET in obsessive-compulsive disorder. European Journal of Nuclear Medicine and Molecular Imaging 2003, 30:1637-1643.
29. Koch W., Radau P.E., Hamann C., Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. Journal of Nuclear Medicine 2005, 46:1109-1118.
30. Koch W., Schaaff N., Popperl G., Mulert C., Juckel G., Reicherzer M., Ehmer-von Geiso C., Moller H.J., Hegerl U., Tatsch K., Pogarell O. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. Journal of Psychiatry and Neuroscience 2007, 32:234-240.
31. Krause J. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics 2008, 8:611-625.
32. Krause K.H., Dresel S.H., Krause J., Kung H.F., Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neuroscience Letters 2000, 285:107-110.
33. la Fougere C., Krause J., Krause K.H., Josef Gildehaus F., Hacker M., Koch W., Hahn K., Tatsch K., Dresel S. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder. Nuclear Medicine Communications 2006, 27:733-737.
34. la Fougere, C., Popperl, G., Levin, J., Wangler, B., Boning, G., Uebleis, C., Cumming, P., Bartenstein, P., Botzel, K., Tatsch, K., 2010. The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. Journal of Nuclear Medicine 51, 581-587.
35. Larisch R., Sitte W., Antke C., Nikolaus S., Franz M., Tress W., Muller H.W. Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder. Nuclear Medicine Communications 2006, 27:267-270.
36. Levy F., Hay D.A., McStephen M., Wood C., Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:737-744.
37. Lindström M.B., Ryding E., Bosson P., Ahnlide J.A., Rosen I., Traskman-Bendz L. Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. European Neuropsychopharmacology 2004, 14:295-300.
38. Malison R.T., Best S.E., van Dyck C.H., McCance E.F., Wallace E.A., Laruelle M., Baldwin R.M., Seibyl J.P., Price L.H., Kosten T.R., Innis R.B. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPEC. American Journal of Psychiatry 1998, 155:832-834.
39. Markon K.E., Chmielewski M., Miller C.J. The reliability and validity of discrete and continuous measures of psychopathology: A quantitative review. Psychological Bulletin 2011, 137:856-879.
40. Mehta M.A., Gumaste D., Montgomery A.J., McTavish S.F., Grasby P.M. The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels. Psychopharmacology (Berl) 2005, 180:654-663.
41. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., Swann A.C. Psychiatric aspects of impulsivity. American Journal of Psychiatry 2001, 158:1783-1793.
42. Moreno M., Cardona D., Gomez M.J., Sanchez-Santed F., Tobena A., Fernandez-Teruel A., Campa L., Sunol C., Escarabajal M.D., Torres C., Flores P. Impulsivity characterization in the Roman high- and low-avoidance rat strains: behavioral and neurochemical differences. Neuropsychopharmacology 2010, 35:1198-1208.
43. Mozley P.D., Acton P.D., Barraclough E.D., Plossl K., Gur R.C., Alavi A., Mathur A., Saffer J., Kung H.F. Effects of age on dopamine transporters in healthy humans. Journal of Nuclear Medicine 1999, 40:1812-1817.
44. Newberg A., Lerman C., Wintering N., Ploessl K., Mozley P.D. Dopamine transporter binding in smokers and nonsmokers. Clinical Nuclear Medicine 2007, 32:452-455.
45. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology 1995, 51:768-774.
46. Peluso M.A., Hatch J.P., Glahn D.C., Monkul E.S., Sanches M., Najt P., Bowden C.L., Barratt E.S., Soares J.C. Trait impulsivity in patients with mood disorders. Journal of Affective Disorders 2007, 100:227-231.
47. Pine A., Shiner T., Seymour B., Dolan R.J. Dopamine, time, and impulsivity in humans. Journal of Neuroscience 2010, 30:8888-8896.
48. Preuss U.W., Rujescu D., Giegling I., Watzke S., Koller G., Zetzsche T., Meisenzahl E.M., Soyka M., Moller H.J. Psychometric evaluation of the German version of the Barratt impulsiveness scale. Nervenarzt 2008, 79:305-319.
49. Reeves S.J., Polling C., Stokes P.R., Lappin J.M., Shotbolt P.P., Mehta M.A., Howes O.D., Egerton A. Limbic striatal D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after excluding potential dissimulators. Psychiatry Research: Neuroimaging 2012, 202:60-64.
50. Reuter M., Kirsch P., Hennig J. Inferring candidate genes for attention deficit hyperactivity disorder (ADHD) assessed by the world health organisation adult ADHD Self-Report scale (ASRS). Journal of Neural Transmission 2006, 113:929-938.
51. Robbins T.W., Arnsten A.F. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annual Review of Neuroscience 2009, 32:267-287.
52. Stanford M.S., Mathias C.W., Dougherty D.M., Lake S.L., Anderson N.E., Patton J.H. Fifty years of the Barratt impulsiveness scale: an update and review. Personality and Individual Differences 2009, 47:385-395.
53. Troiano A.R., Schulzer M., de la Fuente-Fernandez R., Mak E., McKenzie J., Sossi V., McCormick S., Ruth T.J., Stoessl A.J. Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function. Synapse 2010, 64:146-151.
54. van Dyck C.H., Quinlan D.M., Cretella L.M., Staley J.K., Malison R.T., Baldwin R.M., Seibyl J.P., Innis R.B. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. American Journal of Psychiatry 2002, 159:309-312.
55. Verdoux H., van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophrenia Research 2002, 54:59-65.
56. Vink M., Kahn R.S., Raemaekers M., van den Heuvel M., Boersma M., Ramsey N.F. Function of striatum beyond inhibition and execution of motor responses. Human Brain Mapping 2005, 25:336-344.
57. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley S.J., Hitzemann R., Smith G., Fields S.D., Gur R. Dopamine transporters decrease with age. Journal of Nuclear Medicine 1996, 37:554-559.
58. Volkow N.D., Wang G.J., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., Gatley S.J., Logan J., Wong C., Gifford A., Ding Y.S., Hitzemann R., Pappas N. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sciences 1999, 65:7-12.
59. Volkow N.D., Wang G.J., Newcorn J., Fowler J.S., Telang F., Solanto M.V., Logan J., Wong C., Ma Y., Swanson J.M., Schulz K., Pradhan K. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007, 34:1182-1190.
60. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., Logan J., Ma Y., Schulz K., Pradhan K., Wong C., Swanson J.M. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Archives of General Psychiatry 2007, 64:932-940.
61. Volkow N.D., Wang G.J., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F., Fowler J.S., Zhu W., Logan J., Ma Y., Pradhan K., Wong C., Swanson J.M. Evaluating dopamine reward pathway in ADHD: clinical implications. Journal of the American Medical Association 2009, 302:1084-1091.
62. Wallace J.F., Newman J.P., Bachorowski J.A. Failures of response modulation: impulsive behavior in anxious and impulsive individuals. Journal of Research in Personality 1991, 25:23-44.
63. Winstanley C.A., Dalley J.W., Theobald D.E., Robbins T.W. Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 2004, 29:1331-1343.
64. Yang Y.K., Yao W.J., Yeh T.L., Lee I.H., Chen P.S., Lu R.B., Chiu N.T. Decreased dopamine transporter availability in male smokers-a dual isotope SPECT study. Progress in Neuro-psychopharmacology and Biological Psychiatry 2008, 32:274-279.
65. Zandbelt B.B., Vink M. On the role of the striatum in response inhibition. PLoS One 2010, 5:e13848.